Mylan articles & resources on Made-in-China.com

International Paper Bids Over Eur 8.1bn for Irish Packaging Giant Smurfit Kappa

Apr 14, 2015

US-based paper packaging company International Paper is said to be exploring a takeover bid of over €8.1bn for Irish packaging giant Smurfit Kappa. Sky News quoted a source as saying that International Paper was considering an ...

Tags: International Paper, Smurfit Kappa, Paper Packaging

Initiation of Secure Supply Chain Pilot Program to Enhance The Security of Imported Drugs

Feb 19, 2014

The U.S. Food and Drug Administration is announcing the initiation of the Secure Supply Chain Pilot Program to enhance the security of imported drugs. In August 2013, the FDA published a notice in the Federal Register (78 FR 51192) to ...

Tags: Health, Medicine, FDA, Drugs

Zyomyx's MyT4 Point-of-Care CD4 Diagnostic Test Has Received The CE Certificate

Jan 10, 2014

Mylan, Inc. (Nasdaq: MYL) today announced that Zyomyx's MyT4™ point-of-care CD4 diagnostic test has received the CE Certificate of Conformity in the European Union, an important step toward launching this innovative test and expanding ...

Tags: Mylan, Zyomyx's MyT4™point-of-care CD4, diagnostic test, HIV

Mylan Announced That Its U.S. Has Launched Mycophenolic Acid Delayed-Release Tablets

Jan 10, 2014

Mylan Inc. (Nasdaq: MYL) today announced that its U.S.-based subsidiary Mylan Pharmaceuticals Inc. has launched Mycophenolic Acid Delayed-release Tablets, 180 mg and 360 mg. This product is the generic version of Novartis' Myfortic® ...

Tags: Mylan, Mycophenolic Acid Delayed-release Tablets

Monoclonal Antibody Agents Have Been Successfully Used in The Treatment of Tumors

Dec 23, 2013

Currently, monoclonal antibody agents have been successfully used in the treatment of tumors, cancers and other serious diseases as a heavyweight in the biopharmaceutical industry. In 2009-2012, the market size of monoclonal antibody agents ...

Tags: Health, Medicine, Monoclonal Antibody Industry

Mylan Today Announced That Subsidiary Mylan Pharmaceuticals and Partner,Banner Pharmacaps

Dec 19, 2013

Mylan Inc. (Nasdaq: MYL) today announced that its subsidiary Mylan Pharmaceuticals Inc. and partner, Banner Pharmacaps Inc. (a wholly-owned subsidiary of Patheon Inc.), have entered into a settlement and license agreement with Eisai Inc. ...

Tags: Mylan, Targretin Suit, Treatment of Cutaneous Manifestations

INSV Has Reported The US District Court Upheld All Four of The Patents Protecting AzaSite

Oct 10, 2013

InSite Vision Incorporated (INSV) has reported that the US District Court for the District of New Jersey upheld all four of the patents protecting AzaSite, an azithromycin 1% ophthalmic solution, in a patent infringement lawsuit against ...

Tags: Sandoz, Medicine

Mylan Pharmaceuticals Has Introduced Voriconazole for Oral Suspension

Oct 8, 2013

Mylan Pharmaceuticals, a subsidiary of Mylan, has introduced Voriconazole for oral suspension, 40 mg/mL, which is the first generic version of Pfizer's VFEND for oral suspension. The US Food and Drug Administration (FDA) has granted a ...

Tags: Mylan, Antifungal Drug

FDA Laid out The Kind of Scientific Studies Generic Companies Need to Submit

Sep 12, 2013

One of the world's top-selling drugs—GlaxoSmithKline PLC's $8-billion-a-year asthma treatment Advair—became more vulnerable to generic competition after the U.S. Food and Drug Administration issued guidance on the regulatory ...

Tags: Health, Medicine

Mylan Has Obtained FDA Approval for sANDA for GSK's WELLBUTRIN XL

Aug 26, 2013

Mylan has obtained FDA approval for its supplemental abbreviated new drug application (sANDA) for the generic version of GSK's WELLBUTRIN XL, bupropion hydrochloride extended-release tablets USP (XL), 300mg. Bioequivalence study results ...

Tags: FDA Approval, drug application

MWV Has Unveiled Its Smaller,More Discreet Medication Adherence Package

Aug 13, 2013

MeadWestvaco (MWV), a global packaging and packaging technology firm, has unveiled its smaller, more discreet medication adherence package, known as Shellpak Renew with Optilock technology. Designed to fulfill patient and pharmacist ...

Tags: Optilock Technology, packaging

MMV Has Introduced a New Discreet Medication Adherence Package

Aug 12, 2013

Global packaging company MeadWestvaco (MWV) has introduced a new discreet medication adherence package, Shellpak Renew with Optilock technology. Designed to address the needs of patient and pharmacist by enabling patient portability and ...

Tags: MWV, Adherence Package

MeadWestvaco Corp. Introduced Shellpak Renew with OptilockT Technology.

Aug 8, 2013

MeadWestvaco Corp. (MWV), a global leader in packaging and packaging solutions, introduced Shellpak Renew with OptilockT technology. This smaller, more discreet medication adherence package is designed to meet patient and pharmacist needs ...

Tags: Packaging

Mylan Pharmaceuticals and Orion Have Entered Into a Settlement and License Agreement

Jul 26, 2013

Mylan Pharmaceuticals and Orion have entered into a settlement and license agreement, which dismisses the parties pending litigation related to Mylan's filing of an Abbreviated New Drug Application (ANDA) with the US FDA for the generic ...

Tags: Mylan, Orion, Generic Version

Mylan Pharmaceuticals Has Introduced Norethindrone for The Prevention of Pregnancy in US

Jul 18, 2013

Mylan Pharmaceuticals has introduced Norethindrone Tablets USP, 0.35mg, which is the generic version of Watson Laboratories' (now Actavis) Nor-Q.D. tablets, 0.35mg for 28-day cycle, for the prevention of pregnancy in the US. The ...

Tags: Generic Contraceptive Pill, Mylan

Mylan

Related Products